Investors
Where Innovation Meets Impact.
AI-Powered Platforms Transforming Digital Health and Driving Shareholder Value
Why Invest in AIML?
We are pioneering the future of health intelligence by developing and commercializing advanced AI-driven technologies that unlock powerful biometric insights
Backed by a growing portfolio of proprietary technologies and a world-class leadership team, AIML is committed to delivering long-term value to shareholders while improving health outcomes across global markets.
Press Releases
April 25, 2025
AIML Innovations Announces Departure of Tim Daniels from Board of Directors
Read More
April 25, 2025
AIML Optimizes Quantum Sciences Acquisition to Drive Growth & Strategic Focus
Read More
April 22, 2025
AIML Innovations Appoints Jared Adelstein to Board of Directors
Read More
April 15, 2025
AIML Announces Closing of Oversubscribed Private Placement
Read More
April 7, 2025
AIML Updates Terms of Proposed Private Placement Announced
Read More
April 4, 2025
AIML Announces Proposed Private Placement
Read More
Press Releases Archive
Read more
Corporate Governance
Board of Directors
Financials
Read more on CSE
Read more
Charters & Policies
Company Structure
173.3
Million
Shares Outstanding
9.1
Million
Options
109.4
Million
Warrants Outstanding
291.8
Million
Fully Diluted